טוען...
Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis
BACKGROUND: The risk of prostate cancer-specific mortality (PCSM) following a diagnosis of prostate cancer may improve after patients have survived a number of years after diagnosis. We sought to determine long-term conditional PCSM for patients with stage T4, N1, or M1 prostate cancer. METHODS: We...
שמור ב:
| הוצא לאור ב: | Radiat Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4518568/ https://ncbi.nlm.nih.gov/pubmed/26220664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0470-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|